pharmaceuticals
Excessive protection of intellectual rights is not always an incentive for developing innovations and attracting investments
more
26.05.2017
FAS: the support system for Russian pharmaceutical companies should not be build up on restricting the number of biddersmore
Russian pharmaceutical manufacturers should be supported through reducing administrative costs and developing export
more
Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev reviewed large-scale changes in the pharmaceutical sector in the past ten years
more
FAS asked medical institutions to submit information about the issue related to absence of approved licensing requirements
more
The company is suspected of fixing monopolistically high price for “Tyverb” medicinal drug
more